Brief: Guard Therapeutics International Updates On Strategic Review
Feb 5 (Reuters) - Guard Therapeutics International AB (publ) GUARD.ST: UPDATES ON STRATEGIC REVIEW REVIEW IS EXPECTED TO BE COMPLETED DURING Q1 OF 2026 LIQUIDATION CONSIDERED IF NO STRATEGIC ALTERNATIVES NUMBER OF PARTIES HAVE EXPRESSED INTEREST IN MERGER OR RTO WITH CO Source text: ID:nMFN6zYGGL Further company coverage: GUARD.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover